Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis

Current Opinion in Critical Care

Volumn 19, Issue 5, 2013, Pages 453-460

  Schuetz, Philipp ^a   Raad, Issam ^b   Amin, Devendra N ^c  

^a University Department of Medicine   (Switzerland)

^b UNIVERSITY OF TEXAS   (United States)

^c Morton Plant Hospital   (United States)

Author keywords

Antibiotic stewardship; Intensive care unit; Procalcitonin; Serial measurement

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ALGORITHM; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INTENSIVE CARE UNIT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; RESPIRATORY TRACT INFECTION; REVIEW; RISK; SEPSIS; STRATIFICATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL CARE; DECISION MAKING; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTENSIVE CARE UNITS; PROTEIN PRECURSORS;

EID: 84885020888     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328363bd38     Document Type: Review

References (60)

1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intens Care Med 2013; 39:165-228.
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310.
3. Vincent JL. Dear SIRS, Im sorry to say that I dont like you. Crit Care Med 1997; 25:372-374.
4. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005; 353:1332-1341.
5. Shapiro N, Howell MD, Bates DW, et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006; 48:583-590; 590 e581.
6. Schuetz P, Haubitz S, Mueller B. Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care? Curr Opin Crit Care 2012; 18:341-349.
7. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003; 138:W1-W12.
8. Bachmann LM, Juni P, Reichenbach S, et al. Consequences of different diagnostic gold standards in test accuracy research: Carpal Tunnel Syndrome as an example. Int J Epidemiol 2005; 34:953-955.
9. Pizzo PA. Evaluation of fever in the patient with cancer. Eur J Cancer Clin Oncol 1989; 25 (suppl 2):S9-S16.
10. Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28:977-983.
11. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-Analysis. Lancet Infect Dis 2013; 13:426-435.
12. Shomali W, Hachem R, Chaftari AM, et al. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer 2012; 118:5823-5829.
13. Al Shuaibi M, Bahu RR, Chaftari AM, et al. Pro-Adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis 2013; 56:943-950.
14. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873.
15. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
16. Schuetz P, Wolbers M, Christ-Crain M, et al. Prohormones for prediction of adverse medical outcome in community-Acquired pneumonia and lower respiratory tract infections. Crit Care 2010; 14:R106.
17. Theodorou VP, Papaioannou VE, Tripsianis GA, et al. Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheterrelated bloodstream infections in selected critically ill patients: a prospective observational study. BMC Infect Dis 2012; 12:247.
18. Coelho LM, Salluh JI, Soares M, et al. Patterns of c-reactive protein RATIO response in severe community-Acquired pneumonia: a cohort study. Crit Care 2012; 16:R53.
19. Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009; 394:221-226.
20. Hochreiter M, Kohler T, Schweiger AM, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009; 13:R83.
21. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008; 177:498-505.
22. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010; 375:463-474.
23. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-Analysis. Clin Infect Dis 2012; 55:651-662.
24. Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011; 39:2048-2058.
25. Karlsson S, Heikkinen M, Pettila V, et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010; 14:R205.
26. Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 2012; 141:1063-1073.
27. Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34:2596-2602.
28. Schuetz P, Maurer P, Punjabi V, et al. Procalcitonin decrease over 72 h in US critical care units predicts fatal outcome in sepsis patients. Crit Care 2013; 17:R115.
29. Johansen ME, Jensen JU, Lundgren JD. Antibiotics in intensive care: too little or too much? Crit Care Med 2011; 39:1849-1851.
30. Schuetz P, Mueller B. To escalate or to de-escalte-that is the question. Crit Care Med 2011; 39:2590.
31. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
32. Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med 2011; 6 (Suppl 1):S4-S15.
33. Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med 2009; 179:434-438.
34. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Wkly 2009; 139:318-326.
35. Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86:396-404.
36. Muller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-Acquired pneumonia: a prospective cohort trial. Chest 2010; 138:121-129.
37. Becker KL, Nylen ES, White JC, et al. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89:1512-1525.
38. Linscheid P, Seboek D, Zulewski H, et al. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 2005; 146:2699-2708.
39. Linscheid P, Seboek D, Schaer DJ, et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-Activated adipocytes. Crit Care Med 2004; 32:1715-1721.
40. Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-Associated pneumonia: a randomised study. Eur Respir J 2009; 34:1364-1375.
41. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011; 171:1322-1331.
42. Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012; 9:CD007498.
43. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2007; 177:498-505.
44. Annane D, Maxime V, Faller JP, et al. Procalcitonin levels to guide antibiotic therapy in adults with nonmicrobiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open 2013; 3:.
45. Layios N, Lambermont B, Canivet JL, et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 2012; 40:2304-2309.
46. Schuetz P, Mueller B. It is all about risk-Adapted algorithms. Crit Care Med 2013; 41:e27.
47. Schuetz P, Batschwaroff M, Dusemund F, et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a poststudy survey. Eur J Clin Microbiol Infect Dis 2010; 29:269-277.
48. Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in real life: an international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012; 172:715-722.
49. Hohn A, Schroeder S, Gehrt A, et al. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC Infect Dis 2013; 13:158.
50. Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 2005; 135:451-460.
51. Kruger S, Ewig S, Papassotiriou J, et al. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Respir Res 2009; 10:65.
52. Muller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-Acquired pneumonia: a prospective cohort trial. Chest 2010; 138:121-129.
53. Kruger S, Ewig S, Kunde J, et al. Assessment of inflammatory markers in patients with community-Acquired pneumonia-influence of antimicrobial pretreatment: results from the German competence network CAPNETZ. Clin Chim Acta 2010; 411:1929-1934.
54. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-Analysis. Crit Care Med 2006; 34:1996-2003.
55. Hunziker S, Hugle T, Schuchardt K, et al. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am 2010; 92:138-148.
56. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006; 10:R145.
57. Schuetz P, Affolter B, Hunziker S, et al. Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study. Eur J Clin Invest 2010; 40:376-381.
58. Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Criti Care Med 2011; 39:2048-2058.
59. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrugresistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917-1924.
60. Assink-de Jong E, de Lange DW, van Oers JA, et al. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients. BMC Infect Dis 2013; 13:178.